Showing results (521-530 of 1,570) with videos related to

Sort By:
Pageof 157
Journal of the Endocrine Society|November 24, 2025
In Vivo Inhibition of Dipeptidyl Peptidase 4 and Neprilysin Activity Enables Measurement of GLP-1 Secretion in Male RatsKatrine D Galsgaard, Valentina Abba, Rune E Kuhre, et al.
The Journal of Biological Chemistry|July 22, 1994
Proglucagon processing in porcine and human pancreasJ J Holst, M Bersani, A H Johnsen, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|March 29, 2003
No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjectsL B Sørensen, A Flint, A Raben, et al.
Regulatory Peptides|January 1, 1987
Do enkephalins participate in vagal activation of gastric acid secretion in man?B Stenquist, T Lind, U Haglund, et al.
Diabetes|June 28, 2000
Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetesA Vella, P Shah, R Basu, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|August 24, 2001
Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in ratsK Ljungmann, B Hartmann, P Kissmeyer-Nielsen, et al.
Pancreas|April 15, 2000
Tachykinins in the porcine pancreas: potent exocrine and endocrine effects via NK-1 receptorsP T Schmidt, K Tornøe, S S Poulsen, et al.
The Journal of Physical Chemistry. B|December 7, 2007
Continuum simulations of acetylcholine consumption by acetylcholinesterase: a Poisson-Nernst-Planck approachY C Zhou, Benzhuo Lu, Gary A Huber, et al.
Digestive Diseases and Sciences|April 1, 1993
Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in manA Wettergren, B Schjoldager, P E Mortensen, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1996
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patientsB Willms, J Werner, J J Holst, et al.
Pageof 157